INTRODUCTION
============

Pleomorphic adenoma (PA) ranks as the commonly occurring tumor and constitutes up to two-thirds of all salivary gland neoplasms.^[@B1]^ Pleomorphic adenoma was first termed by Willis.^[@B2]^ In the earlier years, it was also referred as mixed tumor, enclavoma, branchioma, endothelioma, endochroma, etc.^[@B3]^ The occurrence is mostly situated parotid glands (85%) followed by minor salivary glands (10%) and the submandibular glands (5%).^[@B4]^ Adult females in the third to fifth decade are most commonly affected with PA. The World Health Organization defines PA as a tumor which is localized and presents pleomorphic or mixed characteristic of epithelial origin which is interwoven with mucoid tissue, myxoid tissue, and chondroid masses.

Adenomas mostly originate in the superficial lobe but may occasionally invade the deeper tissues of the gland and the parapharyngeal space. Pleomorphic adenoma generally presents as a slowly progressing swelling, nonsymptomatic, and not involving facial nerve.^[@B5]^ Although PA principally manifests in the parotid glands, it can also be located in hard palate and soft palate glands of saliva, upper lip, cheek, tongue, and floor of the mouth.^[@B6]^

The term "pleomorphic adenoma" is derived due to morphological complexity of the tumor between individuals and glands. Pleomorphic adenoma presents pathognomic histopathologic features. It is a single cell that differentiates into either epithelial or myoepithelial cell and not just concurrent multiplication of carcinogenic cells of epithelium and myoepithelium.

The tumor has three components: an epithelial component, myoepithelial cell component, and mesenchymal component. The recognition of PA is conceptualized on the identification of these three components. Histological presentation of PA shows a variable pattern of epithelium in a loose fibrous stroma of myxoid, chondroid, or mucoid type. Myoepithelial cells are of polygonal shape with a pale eosinophilic cytoplasm. The diagnosis of pleomorphic adenoma with certainty is microscopic identification.^[@B7]^

MATERIALS AND METHODS
=====================

A literature search in English was carried out utilizing PUBMED the databases in identification of cases regarding PA. Synonyms such as mixed tumor and salivary gland tumors were also used. The terms used for literature search were PA, mixed tumor, reviews, and case reports. Case reports before the year 2000 were not included for the present review. An independent researcher searched the databases and identified 68 relevant studies. Reference checks of the cases identified were also made to help snowballing or networking of the cases.

The outcome criteria were not predefined but were built as the literature review progressed. A table was tabulated regarding author, year of publication, age, gender, lesion associated with pain, location, encapsulation, multinodular, invasion into surrounding tissues, and treatment opted for each of the case report included ([Flowchart 1](#F1){ref-type="fig"}).

Inclusion Criteria
------------------

-   All case reports regarding PA

-   Literature reviews of articles on PA

-   Reports or literature documented in English language.

![Literature search flowchart for systematic review on PA](ijcpd-13-284-g001){#F1}

Exclusion Criteria
------------------

-   Reports documented in languages other than English.

-   Dissertation or pages of textbook relating to PA.

RESULTS
=======

Our search obtained 68 articles in Journal of Web of which 16 were excluded after reading the abstracts. Twenty-two full-text articles published in the English language were included for the review purpose, which met the inclusion criteria of the reviewers. Studies included in the review were Tandon et al.,^[@B8]^ Taiwo et al.,^[@B9]^ Farhat et al.,^[@B10]^ Panda et al.,^[@B11]^ Celik,^[@B12]^ Balan et al.,^[@B13]^ Kaul et al.,^[@B14]^ Mittal et al.,^[@B15]^ Kamala et al.,^[@B16]^ Bagga et al.,^[@B17]^ Modak et al.,^[@B18]^ Jain et al.,^[@B19]^ Verma et al.,^[@B20]^ Dhir et al.,^[@B21]^ Saito et al.,^[@B22]^ Swarnagowri et al.,^[@B23]^ Nagaraj et al.,^[@B24]^ Rahnama,^[@B25]^ Sunil,^[@B26]^ Aggarwal et al.,^[@B27]^ Kumar et al.,^[@B28]^ and Shrestha et al.^[@B29]^

Mean age of PA occurrence was 44.14 years (range: 13--75 years). Pleomorphic adenoma definitely showed a female predilection with male--female ratio of 8:13. The most commonly located site was among the reports reviewed were on the left and right side of the neck (42.8%), followed by its occurrence in the palate, upper lip, soft palate, nasopharynx, right submandibular region, external auditory canal, and left ear lobule ([Table 1](#T1){ref-type="table"}).

DISCUSSION
==========

The cause of PA is still obscure. The exact etiology is obscure although the incidence increases from 15 to 20 years after exposure to radiation. Few studies have suggested an association of the tumor with simian virus 40 (SV 40). Use of tobacco, genetical predisposition, and exposure to chemicals are also thought to play a role in the disease etiology.^[@B30]^ Molecular studies and cytogenetics have postulated chromosomal aberration of 8q12 and 12q15.

Pleomorphic adenomas mostly occur in the young- and middle-aged adults, between 30 and 60 years. The literature reports suggest female predilection. Location of occurrence is predominantly in the parotid gland occurring in the superficial lobe and presenting as a swelling on the ramus of the mandible in front of the ear. Fewer lesions grow in a medial direction between the ascending ramus and the stylomandibular ligament that shows in the lateral pharyngeal wall or soft palate. It appears as an irregular nodular lesion that is firm in consistency. Areas of cystic degeneration can be palpated if it is superficial and does not show any fixation. Pleomorphic adenoma in the minor salivary glands mostly occurs in the palate followed by upper lips and buccal mucosa.^[@B2],[@B31]^ It is generally asymptomatic, with no pain and facial nerve involvement. If not intervened in the early stages, PA can grow to grotesque proportion. A few cases may transform into malignancy.

In cut section, the mass appears as an irregular ovoid mass with well-defined borders, which may be covered by an incomplete fibrous capsule or remain unencapsulated. The consistency may be rubbery, fleshy, or mucoid interspersed with areas of hemorrhage and infarction.^[@B24]^

The tumor confirmation is made by computed tomography (CT) and Magnetic resonance imaging (MRI). MRI is preferred as it presents better delineation, elaborate tumor margin, and the tumor location with respect to its surrounding tissues. But for differentiating malignancy and benign lesions, Fine-needle aspiration biopsy (FNAB) is used. Although these tumors are encapsulated, they still are excised with adequate margins involving surrounding normal tissues. This is because of pseudopodic exhibits microscopic extensions into the surrounding tissues because of dehiscences in false capsule. For this reason, incisional biopsy is avoided to prevent spillage of tumor cells.^[@B5]^

Pleomorphic adenomas generally present as a rounded, well-demarcated mass, or masses which is less than 6 cm in its greatest dimension. The clinical presentation of PA is generally a slow-growing, asymptomatic, and unilateral firm mass that can enlarge in size if not treated. Pleomorphic adenomas of the minor salivary glands mostly occurs in the soft and hard palate due to greater concentration of salivary glands in these location and typically presents as a firm or rubbery submucosal mass either without ulceration or surrounding ulceration.^[@B32]^

Although PA presents as an asymptomatic mass, facial nerve weakness may be found in chronic neglected parotid gland tumors.^[@B33],[@B34]^ In case of deep lobe involvement, an oral retrotonsillar mass/parapharyngeal space tumor may emerge.^[@B35]^ Although they are encapsulated, some parts of the capsule may not be fully developed. This can cause expansible growth-producing protrusions into the surrounding gland that renders enucleation of the tumor at recurrence risk.^[@B36]^

Surgical excision of the mass is the most opted treatment. Only one report^[@B15]^ treated PA with enucleation. In PA occurring in the superficial lobe of parotid gland, superficial parotidectomy with facial nerve preservation is done. Total parotidectomy is done if tumors involve the deep lobe. Pleomorphic adenoma in minor salivary glands is treated with wide local excision along with involved periosteum or bone. Enucleation is not the treatment of choice as it can lead to high local recurrence. Prognosis of PA is good with 95% cure rate. As the tumor is radio resistant, radiotherapy is not indicated.^[@B37],[@B38]^

Clinically, PA can have differential diagnosis of palatal abscess, odontogenic cyst, nonodontogenic cyst, soft tissue tumors-like fibroma, lipoma, neurofibroma, neurilemmoma, lymphoma, or other salivary gland tumors. Palatal abscess can be differentiated by identifying the source of palatal abscess which would be a nonvital tooth in the immediate surroundings. Odontogenic and nonodontogenic cyst do not exhibit a cystic nature during exploration into the mass.^[@B39]^

Because of its varied histopathological presentation, it may be confused with myoepithelioma, adenoid cystic carcinoma, mucoepidermoid carcinoma, and basal cell adenoma. Myoepithelioma lacks the typical feature of glanduloductal differentiation and the absence of chondromyxoid or chondroid foci. Adenoid cystic carcinoma can be identified because of its infiltrative growth pattern and tendency for perineural invasion. The intermediary cells are a common feature in mucoepidermoid carcinoma and pleomorphic adenoma. Although the intermediary cells have of the mucoepidermoid carcinoma produce extracellular material, they do not have the ability to create myxochondroid stroma.

###### 

The list of case reports reviewed on pleomorphic adenoma

  *Investigator*                     *Pain*    *Location*                           *Age (years)*   *Gender*   *Encapsulated*   *Multinodular*   *Invasion into adjacent tissues*   *Treatment opted*
  ---------------------------------- --------- ------------------------------------ --------------- ---------- ---------------- ---------------- ---------------------------------- -------------------------------------------------------
  Tandon et al., 2018^[@B8]^         Present   Left side of palate                  28              M          No               No               No                                 Surgical excision
  Taiwo et al., 2018^[@B9]^          Absent    Upper lip                            33              M          No               No               No                                 Surgical excision
  Farhat et al., 2018^[@B10]^        Absent    Left side of neck                    53              M          Yes              No               No                                 Surgical excision
  Panda et al., 2018^[@B11]^         Absent    Soft palate                          72              M          Yes              No               No                                 Complete excision
  Celik et al., 2018^[@B12]^         Absent    Nasopharynx                          51              F          Yes              No               No                                 Lateral rhinotomy with transnasal endoscopic approach
  Balan et al., 2017^[@B13]^         Absent    Left maxillary labial mucosa         72              F          Yes              Yes              No                                 Surgical excision
  Kaul et al., 2017^[@B14]^          Absent    Cheek                                36              F          Yes              No               No                                 Surgical excision
  Mittal et al., 2017^[@B15]^        Absent    Left side of the face                26              M          Yes              No               No                                 Enucleation
  Kamala et al., 2016^[@B16]^        Absent    Palate                               40              F          Yes              No               No                                 Surgical excision
  Bagga et al., 2016^[@B17]^         Absent    Right submandibular region           50              M          Yes              No               No                                 Excision of submandibular gland with mass
  Modak et al., 2016^[@B18]^         Absent    Right side of the face               39              F          Yes              No               No                                 Surgical excision
  Jain et al., 2015^[@B19]^          Absent    Left side of the face                50              F          Yes              No               No                                 Excision
  Verma et al., 2014^[@B20]^         Absent    Left side of the cheek               42              F          Yes              No               No                                 Surgical excision
  Dhir et al., 2014^[@B21]^          Absent    Left lower one third of face         35              M          Yes              No               No                                 Superficial parotidectomy of left parotid gland
  Saito et al., 2014^[@B22]^         Absent    External auditory canal              40              M          Yes              No               No                                 Retroauricular surgical approach
  Swarnagowri et al., 2014^[@B23]^   Absent    Hard palate                          13              F          Yes              No               No                                 Not known
  Nagaraj et al., 2014^[@B24]^       Absent    Left side of the face                75              F          Yes              Yes              Yes                                Excision with removal of periosteum and bone involved
  Rahnama et al., 2013^[@B25]^       Absent    Hard palate                          47              F          Yes              No               No                                 Surgical excision
  Sunil et al., 2013^[@B26]^         Absent    Angle of the mandible (right side)   62              F          Yes              No               No                                 Surgical excision
  Aggarwal et al., 2012^[@B27]^      Absent    Right side of face                   55              F          Yes              No               No                                 Surgical excision
  Kumar et al., 2011^[@B28]^         Absent    Left ear lobule                      28              F          Yes              No               No                                 Surgical excision
  Shrestha et al., 2010^[@B29]^      Absent    Upper lip                            27              F          No               No               No                                 Surgical excision with lip splitting incision

Malignancy of PA occurs as three forms: carcinoma ex-pleomorphic adenoma (CEPA), carcinosarcoma, and metastasizing pleomorphic adenoma (MPA), of which the last two rarely occur.^[@B40],[@B41]^

A systematic review conducted by Knight et al. which included a total of 81 cases of MPA reported that the most common sites for MPA were bone, lung, and cervical lymph nodes with an occurrence of 36.6% (28 cases), 33.8% (26 cases), and cervical lymph nodes 20.1% (17 cases), respectively. Other sites included kidneys (8.6%), cutaneous (8.6%), hepatic (4.9%), and brain (3.7%).^[@B42]^

The risk of recurrence of PA is generally associated with inadequate surgical procedure, which could have been spillage of tumor or tumor capsule. Recurrent PA occurs as multiple, separate nodules. Surgical risks involved are pseudopodia, capsular penetration, and tumor rupture.^[@B43]^

The study included articles on English language only, incorporating an element of selection bias.

CONCLUSION
==========

Pleomorphic adenomas are benign salivary gland neoplasms that can grow into extensive sizes. They need to be diagnosed early. Complete excision of the tumor is the definitive treatment, as enucleation can result in recurrence. Facial nerve has to be preserved if PA occurs in the parotid gland. Even after removal, a long-term follow-up is necessary to check for recurrence.
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